Afrezza from Mannkind
Afrezza (insulin human) Inhalation Powder is the only ultra rapid-acting inhaled insulin indicated to improve glycemic control in adult patients with diabetes mellitus. Available by prescription only.
For complete information, visit Mannkind Corporation
Afrezza is a ultra rapid-acting inhaled insulin taken at mealtime and helps control postprandial plasma glucose (PPG) in adults with type 1 or type 2 diabetes mellitus.
Dose is inhaled via single use cartridges.
Available in 4-unit, 8-unit and 12-unit single-dose cartridges of insulin powder. For Afrezza doses exceeding 12 units, patients may use a combination of existing cartridge strengths.
BluHale Pro is an accessory device, designed by MannKind, that mounts onto the inhaler to facilitate healthcare professionals in training patients on proper inhalation technique and handling.*
The BluHale app is designed to be used with the BluHale PRO device by healthcare professionals and is available for Android and IOS devices.
BluHale Vis is coming soon!
*It is important to keep in mind that BluHale PRO is not a diagnostic device.
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or healthcare provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit diabeteseducator.org.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.